BC
AGN

Bruce & Co’s Allergan plc AGN Stock Holding History

Bruce & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-55,900
Closed -$9.89M – 43
2020
Q1 		$9.89M Sell
55,900
-5,000
-8% -$941K 2.28% 16
2019
Q4 		$11.6M Sell
60,900
-20,000
-25% -$3.61M 2.27% 15
2019
Q3 		$13.6M Hold
80,900
– – 2.83% 14
2019
Q2 		$13.5M Sell
80,900
-15,700
-16% -$2.17M 2.89% 15
2019
Q1 		$14.1M Sell
96,600
-20,000
-17% -$2.9M 2.76% 14
2018
Q4 		$15.6M Buy
+116,600
New +$19.1M 3.32% 13

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Bruce & Co's AGN Position: Q2 2020 in Review

Bruce & Co sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 55,900 shares — an estimated $9.89M sold.

Bruce & Co first reported a position in AGN in Q4 2018 and held it in 6 quarters. The position peaked at $15.6M in Q4 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Bruce & Co reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Bruce & Co sold 55,900 Allergan plc shares in Q2 2020, an estimated $9.89M.
  • Bruce & Co first reported a position in Allergan plc in Q4 2018 and held it in 6 quarters.
  • Bruce & Co's Allergan plc position peaked at $15.6M in Q4 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Bruce & Co's 13F filing for Q2 2020, filed 14 Aug 2020.